Lytica Therapeutics, Inc. — Form D
Lytica Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-11. $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-11
- Form: D
- Accession: 0002015049-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $6.0M
- Investors: 17
- Date of first sale: 2025-02-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-543463
Issuer
- Name: Lytica Therapeutics, Inc.
- CIK: 0002015049
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 840 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139
- Phone: 617-475-7374
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| JEAN-FRANCOIS DUCREST | Director | CAMBRIDGE, MA |
| JAMES LATORRE | Director | CAMBRIDGE, MA |
| DANIEL MACAYA | Director | CAMBRIDGE, MA |
| RIDA MOURTADA | Director | CAMBRIDGE, MA |
| RIDA MOURTADA | Executive Officer | CAMBRIDGE, MA |
| JAMES LATORRE | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (2)
More